A humane, non-surgical oral fertility platform for mammals — a scalable, non-lethal alternative to culling for the overpopulated and invasive species reshaping our ecosystems. Proof-of-concept established in cats and rodents.
From feral cats and rodents to wild boar, deer, and coyotes, overpopulated and invasive mammals are among the most destructive forces facing ecosystems, economies, and communities worldwide — collapsing native biodiversity, spreading disease, and damaging crops and infrastructure. The control programs meant to help — culling, poisoning, trapping — never solve the problem at its source: reproduction.
And these are only examples. Multiply them across wild boar, deer, and other overpopulated mammals on every continent, and the true ecological, economic, and humane cost is far greater. The world needs a humane way to manage reproduction — at scale, across species.
Invasive and overpopulated species aren't only an ecological problem — they are one of the largest and fastest-growing economic burdens on Earth.
Figures are conservative minimums; global costs standardized to 2017 US$ (InvaCost methodology). Reported costs consistently understate the true total.
Effective on paper — and unacceptable in practice: inhumane, ecologically damaging (secondary poisoning up the food chain), and rejected by the communities who live with these animals.
Humane, but it doesn't scale: every animal means a trap, an anesthetic, a surgeon, and a recovery — slow, costly, and impossible to sustain across species and continents.
The world has been forced to choose between what's humane and what's scalable. CommuniTreat is built to end that trade-off.
CommuniTreat is a non-surgical, orally delivered fertility technology built on dual plant-derived botanical actives — eaten by choice in ordinary food, acting on a reproductive pathway conserved across mammals. Not a single product for a single animal: a delivery-and-mechanism platform, engineered for breadth, with proof-of-concept demonstrated in cats and rodents.
Concentrates its effect on reproductive tissue, sparing surrounding organs — shown in both cats and rodents.
Plant-derived botanical actives rather than synthetic hormones — a gentler route to fertility control.
Designed to leave natural behavior intact, so treated animals keep their place in the ecosystem.
Developed with safety as a first principle. No clinical signs of toxicity and zero mortality were observed across the feline study.
Eaten by choice from feed — no trapping, no handling, no stress to the animal or the caregiver.
Two very different mammals, one consistent result. That cross-species reproducibility is our strongest evidence that the approach generalizes.
The same platform is designed to extend to other overpopulated mammals as a humane alternative to culling — each a validation step ahead of us, built on a mechanism we've already demonstrated twice.
A controlled feline proof-of-concept and the rodent studies that came before it point the same direction — a high effect rate, selective action, delivered through the animal's normal diet.
Conducted with the Hebrew University of Jerusalem's veterinary teaching hospital and study lead Dr. Smadar Tal: 26 cats enrolled, 22 analyzable, over a 20-week feeding period — the actives delivered in ordinary twice-daily food.
Early-stage proof-of-concept, not outcomes from a marketed product.
Before the feline work, CommuniTreat established the biological foundation of the platform in rodents. In a repeated-dose study, 100% of treated males showed the targeted testicular changes while the accessory reproductive glands remained normal — the same tissue-selective signature later reproduced in cats. Two species, one consistent result: evidence we're acting on a conserved biological pathway, not a single-species quirk.
Laboratory proof is the beginning. The next milestone is showing the platform works in the field, at colony scale, in the messy conditions of the real world.
CommuniTreat has an approved field study on the Big Island of Hawaii — a community cat colony run over about a year, with the actives delivered simply by drizzling a palatable syrup onto the colony's normal food.
It's designed to demonstrate what a controlled study can't: real-world uptake, at-scale delivery, and population-level fertility control in an open colony — validated with established field-operations and colony-data partners on the ground. Hawaii is the ideal proving ground: its native wildlife is under acute pressure from free-roaming cats, and its communities are actively seeking humane, non-lethal alternatives.
We start where the need — and the data — are clearest, inside a market measured in the tens of billions.
One proven platform, three widening rings of demand — a focused feline beachhead, expanding into rodent control, and growing into the full animal-health market.
We're collaborating with field and data partners to move from proof-of-concept to real-world evidence.
Collaborations reflect active, non-binding working relationships.
Because the technology is delivered through feed, we are pursuing a feed-supplement route — a faster, more accessible path than a full pharmaceutical filing, without cutting corners on evidence.
First market entry via the feed-supplement path — the fastest regulatory route.
Our lead beachhead — backed by the proof-of-concept and the field study now underway.
The long-horizon opportunity: humane population management across broader ecosystems.
A team that pairs deep veterinary and reproductive science with the discipline to bring it to market.
Patent-pending across Europe, the US, China, India, Australia, Canada, and Israel.
Whether you want to run a study with us, back the science, or bring it to a new market — there's a place for you in what comes next. Tell us where you fit, and we'll be in touch.